Basilar Artery Occlusion Chinese Endovascular Trial in Patients With Large Core Infarct

NANot yet recruitingINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

November 30, 2028

Conditions
Basilar Artery OcclusionIschemic StrokeLarge Core Infarct
Interventions
PROCEDURE

Endovascular Therapy Plus Best Medical Treatment

Participants assigned to the endovascular therapy arm will receive EVT in addition to best medical treatment. EVT must be initiated within 24 hours of symptom onset and completed within 3 hours of groin puncture. After evaluating vascular anatomy, neurointerventionalists will determine the most appropriate strategy based on the presence of proximal stenosis, occlusion morphology, and vessel tortuosity. Permitted interventions include mechanical thrombectomy, stent thrombectomy, aspiration thrombectomy, intra-arterial thrombolysis, balloon angioplasty, and stent implantation. The choice of treatment approach is left to the discretion of the treating physician, and combinations of techniques are allowed.

DRUG

Best Medical Treatment Alone

Participants in this arm will receive best medical treatment and maximal supportive care according to current stroke guidelines, without the use of mechanical thrombectomy or any intra-arterial intervention.

Trial Locations (1)

100053

Xuanwu Hospital, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER